What the Theralase news means for the Company moving forward
Roger Dumoulin-White, CEO and President of Theralase elaborates on the news release today.
Click download link to listen on this device: Download Show
Great news – and an immune response.Look forward to the weekend show.
Thx very much for the update. Retail investor rarely had such contact. So thank you all for that.
In that regard, please explore the fluorescing properties and how using those properties could be used to procedurally to achieve a higher kill percentage.
Also has the company – or is the company planning to allow some of the rats to live longer (as with the mouse study) to test for potential recurrence and/or an immune response as these results seem to imply could be happening.
Also regarding fluorescence: It would seem that an iterative process will be applied to humans to insure 100% destruction of the cancer involved (in this case bladder of course). As such, it would seem this iterative process would be under refinement as part of these ongoing studies.
Also with sensing technology available today, it would seem computer aided detection of fluoresced cells would be part of a longer term plan (time and resources allowing).
I am not a research biologist nor do I work in the field but I am not aware of any compound available or under study that provides the dual function of fluorescing and light induced destruction. This appears to be huge and adds considerable intrinsic value to the company’s discoveries. Pls comment.
Yes, always good to know more.
Keep up the good work!
Thanks!